Leidos Holdings Inc
NYSE:LDOS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
107.66
201.39
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Leidos Holdings Inc
Leidos Holdings Inc
Common Shares Outstanding
Leidos Holdings Inc
Common Shares Outstanding Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Leidos Holdings Inc
NYSE:LDOS
|
Common Shares Outstanding
$133.3m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
|
|
Jacobs Engineering Group Inc
NYSE:J
|
Common Shares Outstanding
$124.3m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
TransUnion
NYSE:TRU
|
Common Shares Outstanding
$194.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
Equifax Inc
NYSE:EFX
|
Common Shares Outstanding
$123.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Verisk Analytics Inc
NASDAQ:VRSK
|
Common Shares Outstanding
$141.4m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-2%
|
|
|
CoStar Group Inc
NASDAQ:CSGP
|
Common Shares Outstanding
$409.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
|
Leidos Holdings Inc
Glance View
Leidos Holdings Inc., a prominent player in the defense, aviation, information technology, and biomedical research sectors, operates at the intersection of innovation and national security. Founded as a spin-off from Science Applications International Corporation (SAIC) in 2013, Leidos has steadily carved out a niche for itself, providing advanced solutions and services to both government and commercial clients. With a mission centered on protecting lives and securing critical infrastructure, the company thrives on its diverse portfolio, which includes defense systems, logistics, cybersecurity, and health services. Through strategic acquisitions and partnerships, Leidos has broadened its capabilities, positioning itself as a trusted partner for federal agencies and commercial enterprises alike. For investors, Leidos presents a compelling opportunity grounded in steady financial performance and growth dynamics. With a revenue-generating moat fueled by long-term contracts primarily with the U.S. government, the company enjoys a stable financial foundation that mitigates risk even in volatile economic climates. As the demand for advanced technology and defense solutions continues to rise, particularly in the realms of cybersecurity and digital transformation, Leidos stands to benefit from favorable market trends. Additionally, its commitment to research and development ensures that it remains at the forefront of technological advancements, potentially increasing shareholder value and dividends over time. In a landscape marked by both challenges and opportunities, Leidos Holdings Inc. shares a story of resilience, innovation, and sustained growth, making it an intriguing prospect for those looking to invest in a company with strong fundamentals and a clear vision for the future.
See Also
What is Leidos Holdings Inc's Common Shares Outstanding?
Common Shares Outstanding
133.3m
USD
Based on the financial report for Sep 27, 2024, Leidos Holdings Inc's Common Shares Outstanding amounts to 133.3m USD.
What is Leidos Holdings Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
6%
Over the last year, the Common Shares Outstanding growth was -3%. The average annual Common Shares Outstanding growth rates for Leidos Holdings Inc have been -2% over the past three years , -1% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet